Author

Eric J. Kort

Van Andel InstituteORCID 0000-0002-9966-7483Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Approach:statistical model· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1

Frequent Co-Authors

Stefan V. JovingeiD· 2 shared Catherine E. KeltyiD· 1 shared Chun LiuiD· 1 shared Edgars GrinsiD· 1 shared Emily Eugster· 1 shared Greg Marco· 1 shared Hsiao-yun Milliron· 1 shared Joseph C. WuiD· 1 shared

Activity by Year

2019-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Stefan V. JovingeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintMar 7, 2020

The inflammasome of circulatory collapse: single cell analysis of survival on extracorporeal life support.

Eric J. Kort, Matthew J. Weiland, Edgars Grins…·Stefan V. Jovinge

The paper uses single-cell RNA sequencing to identify CD8+/CD52+ NKT cells as a survival predictor in patients on VA-ECLS, showing their inverse correlation with IL-6 production.

2 citations

humanscRNA-seq

𝕏 PostBluesky

GenomicsbioRxivPreprintSep 23, 2019

Toxicogenomic identification of repositioned therapy for a monogenic disease

Eric J. Kort, Nazish Sayed, Chun Liu…·Stefan V. Jovinge

The paper uses transcriptomic data to identify potential drug therapies for a monogenic disease by finding FDA-approved drugs with similar transcriptional profiles.

2 citations

humanbulk RNA-seq

𝕏 PostBluesky